Potentiation of DNA replication stress to toxic levels by inhibiting the ATR kinase is a strategy being used to target the chronic DNA replication stress phenotype of cancer cells, and this would be expected to make ATR-deficient cancer cells even more reliant on MiDAS for survival. Here, ATR is linked to cancer.